Jeff Beecham

Equibles does not estimate personal net worth.

About Jeff Beecham

Jeff Beecham has spoken on 1 investor event across 1 company, most recently for Novavax Inc on September 10, 2026. The companies whose calls Jeff Beecham spoke on are classified in the Healthcare sector.

Jeff Beecham on recent calls

“So welcome to the city back to school biotech conference. My name is Jeff Beecham. I'm the senior biopharma analyst. We're thrilled today to have Novavax. We have CFO Jim Kelly and CEO John Jacobs.”

Analyst, Citi’s 2026 BioPharma Back to School Conference · September 10, 2026

Company network

Novavax Inc

NVAX

Biotechnology · Healthcare

1 appearance Latest appearance 2026-09-10

View calls and events

Recent activity

Conference Citi’s 2026 BioPharma Back to School Conference Novavax Inc (NVAX)
2026-09-10